Evidence map›Paper›PMID 28240915›Full record

ArticleJournal of proteome research2017

Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy.

Mingrui An, Ines Lohse, Zhijing Tan, Jianhui Zhu, Jing Wu, Himabindu Kurapati, Meredith A Morgan, Theodore S Lawrence, Kyle C Cuneo, David M Lubman

Abstract read
In one paragraph

Article in Journal of proteome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Diagnostic and prognostic significance of circulating extracellular vesicles in gastrointestinal cancers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. HSP90 multi-functionality in cancer.Frontiers in immunology · 2024
    Review
  10. Review
  11. Effect of radiotherapy on the DNA cargo and cellular uptake mechanisms of extracellular vesicles.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Review
  12. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.Journal of experimental & clinical cancer research : CR · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mingrui AnDepartment of Surgery, University of Michigan Medical Center , Ann Arbor, Michigan 48109, United States.
Ines LohseDepartment of Radiation Oncology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Zhijing TanDepartment of Surgery, University of Michigan Medical Center , Ann Arbor, Michigan 48109, United States.
Jianhui ZhuDepartment of Surgery, University of Michigan Medical Center , Ann Arbor, Michigan 48109, United States.
Jing WuDepartment of Surgery, University of Michigan Medical Center , Ann Arbor, Michigan 48109, United States.
Himabindu KurapatiDepartment of Radiation Oncology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Meredith A MorganDepartment of Radiation Oncology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Theodore S LawrenceDepartment of Radiation Oncology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Kyle C CuneoDepartment of Radiation Oncology, University of Michigan , Ann Arbor, Michigan 48109, United States.
David M LubmanDepartment of Surgery, University of Michigan Medical Center , Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-7731-0232

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer · 1985 to 2026
$68.4M
Translational Research in GI CancerP50CA130810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRENNER, DEAN E. · 2010 to 2016
$11.8M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI PARKER, GRAHAM C · 2014 to 2021
$10.1M
Microsequencing in an Ion Trap/reTOF DeviceR01GM049500 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 1994 to 2016
$3.0M
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 InhibitR01CA163895 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORGAN, MEREDITH A · 2012 to 2016
$1.6M
Orbitrap Velos with ETD for Wayne State ProteomicsS10OD010700 · OD · WAYNE STATE UNIVERSITY · PI STEMMER, PAUL M · 2012 to 2012
$575k
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec AssayR21CA189775 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 2015 to 2016
$371k
NCI NIH HHS P30 CA022453NCI NIH HHS P50 CA130810NCI NIH HHS R01 CA163895NCI NIH HHS R21 CA189775NIEHS NIH HHS P30 ES020957NIGMS NIH HHS R01 GM049500NIH HHS S10 OD010700
6 · The paper itself

Abstract

Pancreatic cancer is the third leading cause of cancer-related death in the USA. Despite extensive research, minimal improvements in patient outcomes have been achieved. Early identification of treatment response and metastasis would be valuable to determine the appropriate therapeutic course for patients. In this work, we isolated exosomes from the serum of 10 patients with locally advanced pancreatic cancer at serial time points over a course of therapy, and quantitative analysis was performed using the iTRAQ method. We detected approximately 700-800 exosomal proteins per sample, several of which have been implicated in metastasis and treatment resistance. We compared the exosomal proteome of patients at different time points during treatment to healthy controls and identified eight proteins that show global treatment-specific changes. We then tested the effect of patient-derived exosomes on the migration of tumor cells and found that patient-derived exosomes, but not healthy controls, induce cell migration, supporting their role in metastasis. Our data show that exosomes can be reliably extracted from patient serum and analyzed for protein content. The differential loading of exosomes during a course of therapy suggests that exosomes may provide novel insights into the development of treatment resistance and metastasis.

Indexed as

Blood ProteinsExosomesFemaleGene Expression Regulation, NeoplasticHumansMaleNeoplasm Recurrence, LocalPancreatic NeoplasmsProteomeBlood ProteinsProteomechemoradiationchemotherapyexosomesiTRAQmetastasispancreatic cancer

Identifiers

PMID28240915
PMCPMC5462613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.